<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级为市场领先者的投资组合，使用智能投资者精选</li>
</ul>
<p>National Healthcare (NHC) 发布了最新消息。</p>
<p>National HealthCare Corporation 于 2026 年 5 月 7 日召开了年度股东大会，出席或通过代理人代表的普通股为 12,216,578 股，符合 15,599,046 股的资格，形成投票所需的法定人数。股东重新选举了董事 Emil E. Hassan、Lisa Piercey 医生和 William A. Adams，任期为三年，强化了董事会领导和公司监督的连续性。</p>
<p>投资者还以咨询方式批准了公司指定高管的薪酬，绝大多数投票支持，反对票和弃权票相对较少。结果表明，股东对董事会的组成和公司高管薪酬实践有着稳固的支持，暗示治理的稳定性和与投资者期望的一致性。</p>
<p><strong>Spark 对 NHC 股票的看法</strong></p>
<p>根据 Spark，TipRanks 的 AI 分析师，NHC 的评级为跑赢大盘。</p>
<p>该评分主要受到强劲的财务表现（更高的盈利能力、强劲的自由现金流和非常低的杠杆率）的推动。技术面也支持该评级，显示出明显的上升趋势和积极的动能。抵消因素包括 TTM 收入的急剧下降和中等范围的估值支持，而最近的公司行动（股息增加和战略性房地产收购）是积极的，但次要。</p>
<p>要查看 Spark 对 NHC 股票的完整报告，请点击这里。</p>
<p><strong>关于 National Healthcare 的更多信息</strong></p>
<p>National HealthCare Corporation 在医疗保健行业运营，通过其设施网络和相关医疗保健业务为持有其普通股的股东提供服务。公司的治理框架包括由股东选举的董事会和其薪酬在年度会议上需接受咨询投票的高管领导。</p>
<p><strong>平均交易量：</strong> 115,695</p>
<p><strong>技术情绪信号：</strong> 买入</p>
<p><strong>当前市值：</strong> 29.6 亿美元</p>
<p>要全面评估 NHC 股票，请访问 TipRanks 的股票分析页面。</p>

National医疗

<p>国家医疗公司（NHC）于 2026 年 5 月 7 日召开了年度股东大会，55% 的合格股份出席。股东们重新选举了董事并批准了高管薪酬，显示出对董事会领导和薪酬政策的强烈支持。Spark 的人工智能分析师将 NHC 评级为 “跑赢大盘”，尽管收入有所下降，但其财务表现依然强劲。NHC 在医疗保健行业运营，市值为 29.6 亿美元，技术情绪信号为 “买入”</p>

<h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级为市场领先者的投资组合，使用智能投资者精选</li>
</ul>
</div><p>National Healthcare ( (NHC) ) has issued an update.</p>
<div class="lb-trans"><p>National Healthcare (NHC) 发布了最新消息。</p>
</div><p>National HealthCare Corporation held its Annual Meeting of Shareholders on May 7, 2026, with 12,216,578 of 15,599,046 eligible common shares represented in person or by proxy, establishing a quorum for voting. Shareholders re-elected directors Emil E. Hassan, Lisa Piercey, M.D., and William A. Adams to new three-year terms, reinforcing continuity in board leadership and corporate oversight.</p>
<div class="lb-trans"><p>National HealthCare Corporation 于 2026 年 5 月 7 日召开了年度股东大会，出席或通过代理人代表的普通股为 12,216,578 股，符合 15,599,046 股的资格，形成投票所需的法定人数。股东重新选举了董事 Emil E. Hassan、Lisa Piercey 医生和 William A. Adams，任期为三年，强化了董事会领导和公司监督的连续性。</p>
</div><p>Investors also approved, on an advisory basis, the compensation of the company’s named executive officers, with a strong majority voting in favor and relatively few votes against or abstentions. The outcomes signal solid shareholder support for both the board’s composition and the company’s executive pay practices, suggesting stability in governance and alignment with investor expectations.</p>
<div class="lb-trans"><p>投资者还以咨询方式批准了公司指定高管的薪酬，绝大多数投票支持，反对票和弃权票相对较少。结果表明，股东对董事会的组成和公司高管薪酬实践有着稳固的支持，暗示治理的稳定性和与投资者期望的一致性。</p>
</div><p><strong>Spark’s Take on NHC Stock</strong></p>
<div class="lb-trans"><p><strong>Spark 对 NHC 股票的看法</strong></p>
</div><p>According to Spark, TipRanks’ AI Analyst, NHC is a Outperform.</p>
<div class="lb-trans"><p>根据 Spark，TipRanks 的 AI 分析师，NHC 的评级为跑赢大盘。</p>
</div><p>The score is driven primarily by strong financial performance (higher profitability, strong free cash flow, and very low leverage). Technicals also support the rating with a clear uptrend and positive momentum. Offsetting factors include the sharp TTM revenue decline and only mid-range valuation support, while recent corporate actions (dividend increase and strategic real-estate acquisition) are constructive but secondary.</p>
<div class="lb-trans"><p>该评分主要受到强劲的财务表现（更高的盈利能力、强劲的自由现金流和非常低的杠杆率）的推动。技术面也支持该评级，显示出明显的上升趋势和积极的动能。抵消因素包括 TTM 收入的急剧下降和中等范围的估值支持，而最近的公司行动（股息增加和战略性房地产收购）是积极的，但次要。</p>
</div><p>To see Spark’s full report on NHC stock, click here.</p>
<div class="lb-trans"><p>要查看 Spark 对 NHC 股票的完整报告，请点击这里。</p>
</div><p><strong>More about National Healthcare</strong></p>
<div class="lb-trans"><p><strong>关于 National Healthcare 的更多信息</strong></p>
</div><p>National HealthCare Corporation operates in the healthcare sector, providing services through its network of facilities and related healthcare operations to shareholders who hold its common stock. The company’s governance framework includes a board of directors elected by shareholders and executive leadership whose compensation is subject to advisory votes at annual meetings.</p>
<div class="lb-trans"><p>National HealthCare Corporation 在医疗保健行业运营，通过其设施网络和相关医疗保健业务为持有其普通股的股东提供服务。公司的治理框架包括由股东选举的董事会和其薪酬在年度会议上需接受咨询投票的高管领导。</p>
</div><p><strong>Average Trading Volume:</strong> 115,695</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 115,695</p>
</div><p><strong>Technical Sentiment Signal:</strong> Buy</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 买入</p>
</div><p><strong>Current Market Cap:</strong> $2.96B</p>
<div class="lb-trans"><p><strong>当前市值：</strong> 29.6 亿美元</p>
</div><p>For a thorough assessment of NHC stock, go to TipRanks’ Stock Analysis page.</p>
<div class="lb-trans"><p>要全面评估 NHC 股票，请访问 TipRanks 的股票分析页面。</p>
</div>

National 医疗的股东支持董事会和高管的薪酬方案